Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)
Oculus Innovative Sciences stock is up in a big way today after announcing that they have received a new U.S. Patent for Microcyn Technology hypochlorous acid in the treatment of atopic dermatitis. During the announcement, here’s what Dr. Bob Northey, SVP for research and development for the company had to say…
“Our intellectual property portfolio is perfectly synced with our new focus on the dermatology market with our direct sales force. The empirical evidence demonstrating Microcyn’s efficacy in the treatment of atopic dermatitis is highly compelling…This new patent provides Oculus market exclusivity for the use of hypochlorous acid with broad ranges of activity in the treatment of atopic dermatitis until the year 2027 when the patent expires.”
As a result of the announcement OCLS is currently (12:29) trading at $1.65 per share after a gain of 9.99% so far today. Given the reason for the climb in the stock, I’m expecting more gains. Of course, with worldwide market conditions struggling, there may be hick-ups along the way. Nonetheless, the pull-backs are likely to prove to be great buying opportunities. So, keep a close eye on this one as it’s likely to grow!
What Do You Think?
Where do you think OCLS is headed and why? Let us know in the comments below!